| Primary |
| Type 2 Diabetes Mellitus |
48.2% |
| Diabetes Mellitus |
16.3% |
| Hypertension |
11.9% |
| Blood Cholesterol Increased |
3.1% |
| Bronchitis |
2.5% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Supplementation Therapy |
2.3% |
| Vitamin Supplementation |
2.1% |
| Mineral Supplementation |
1.6% |
| Blood Pressure |
1.5% |
| Pain |
1.3% |
| Blood Cholesterol |
1.1% |
| Hyperlipidaemia |
1.1% |
| Cardiac Disorder |
0.8% |
| Hypothyroidism |
0.8% |
| Hypersensitivity |
0.7% |
| Atrial Fibrillation |
0.6% |
| Gout |
0.6% |
| Thyroid Disorder |
0.6% |
| Anxiety |
0.6% |
|
| Pancreatitis |
18.2% |
| Blood Glucose Increased |
12.1% |
| Rash |
12.1% |
| Nausea |
8.8% |
| Diarrhoea |
4.5% |
| Drug Ineffective |
4.1% |
| Abdominal Discomfort |
3.7% |
| Glycosylated Haemoglobin Increased |
3.7% |
| Urticaria |
3.7% |
| Dizziness |
3.5% |
| Headache |
3.4% |
| Abdominal Pain |
2.8% |
| Pruritus |
2.8% |
| Vomiting |
2.8% |
| Weight Increased |
2.7% |
| Abdominal Pain Upper |
2.3% |
| Hyperglycaemia |
2.3% |
| Oedema Peripheral |
2.3% |
| Lip Swelling |
2.1% |
| Rash Generalised |
2.1% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
31.4% |
| Hypertension |
16.8% |
| Diabetes Mellitus |
13.7% |
| Atrial Fibrillation |
4.0% |
| Blood Cholesterol Increased |
3.5% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Benign Prostatic Hyperplasia |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.7% |
| Crohn's Disease |
2.7% |
| Blood Glucose Abnormal |
2.2% |
| Blood Glucose Increased |
2.2% |
| Cardiovascular Event Prophylaxis |
2.2% |
| Diabetes Mellitus Management |
2.2% |
| Gout |
1.8% |
| Renal Failure Chronic |
1.8% |
| Supplementation Therapy |
1.8% |
| Epilepsy |
1.3% |
| Glycosylated Haemoglobin Increased |
1.3% |
| Heart Rate Increased |
1.3% |
| Hyperlipidaemia |
1.3% |
|
| Pancreatitis |
12.5% |
| Abdominal Pain Upper |
7.5% |
| Blood Glucose Increased |
7.5% |
| Rash |
7.5% |
| Rhinorrhoea |
7.5% |
| Constipation |
5.0% |
| Dizziness |
5.0% |
| Fatigue |
5.0% |
| Gout |
5.0% |
| Headache |
5.0% |
| Renal Failure Acute |
5.0% |
| Somnolence |
5.0% |
| Swollen Tongue |
5.0% |
| Abdominal Discomfort |
2.5% |
| Acute Pulmonary Oedema |
2.5% |
| Asthenia |
2.5% |
| Carotid Artery Occlusion |
2.5% |
| Chills |
2.5% |
| Cholelithiasis |
2.5% |
| Creatinine Renal Clearance Abnormal |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.1% |
| Diabetes Mellitus |
17.0% |
| Type 2 Diabetes Mellitus |
5.4% |
| Rheumatoid Arthritis |
4.7% |
| Hypertension |
3.9% |
| Blood Cholesterol Increased |
3.2% |
| Cardiac Disorder |
2.5% |
| Blood Pressure |
2.2% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Diabetic Neuropathy |
1.7% |
| Crohn's Disease |
1.5% |
| Renal Transplant |
1.5% |
| Anticoagulant Therapy |
1.2% |
| Atrial Fibrillation |
1.2% |
| Blood Cholesterol |
1.2% |
| Feeling Of Relaxation |
1.0% |
| Migraine |
1.0% |
| Neuropathy Peripheral |
1.0% |
| Psoriasis |
1.0% |
| Back Pain |
0.7% |
|
| Blood Glucose Increased |
12.2% |
| Diabetes Mellitus |
7.3% |
| Dizziness |
7.3% |
| Weight Decreased |
7.3% |
| Cyst |
4.9% |
| Drug Ineffective |
4.9% |
| Injection Site Pain |
4.9% |
| Myocardial Infarction |
4.9% |
| Pain In Extremity |
4.9% |
| Pancreatic Carcinoma |
4.9% |
| Paraesthesia |
4.9% |
| Rash Erythematous |
4.9% |
| Syncope |
4.9% |
| Tremor |
4.9% |
| Wrong Technique In Drug Usage Process |
4.9% |
| Adverse Event |
2.4% |
| Angioedema |
2.4% |
| Arterial Occlusive Disease |
2.4% |
| Blood Testosterone Increased |
2.4% |
| Breast Mass |
2.4% |
|
